LLRS Research Policies and Procedures – Document
Modified Corporate Authorship Guidelines – Document
Limb Lengthening and Reconstruction Society (LLRS) Research Committee Policies & Procedures
February 9, 2017 revised: July 22, 2017 revised August 24, 2017
Chair: Mitchell Bernstein, MD, FRCSC
Members: Austin Fragomen, MD – FragomenA@HSS.EDU
Joseph Hsu, MD – email@example.com
Christopher Iobst, MD – firstname.lastname@example.org
Jessica Rivera, MD – email@example.com
S. Robert Rozbruch, MD – RozbruchSR@hss.edu
Stephen Quinnan, MD – firstname.lastname@example.org
Arvind Nana, MD – Anana@jpshealth.org
Ahmed Hagag, MD – email@example.com
LLRS Research Committee Mission Statement:
• To help drive basic science, translational, and clinical research in the area of Limb Lengthening & Reconstruction
LLRS Research Committee Objectives:
• To support and facilitate collaboration among society members
• To develop research efforts that cross orthopaedic disciplines
• To inform/update AAOS specialty boards of the relevance/significance of such research efforts
• To demonstrate the relevance of our field through timely, effective, and impactful research studies, meetings, and symposia
• The LLRS Board of Directors shall appoint a Research Committee Chair
• The Research Committee Chair shall ask among the LLRS membership for people whom wish to sit on the Research Committee members from the LLRS membership
• The Research Committee position (including the Chair) is a volunteer position
• Investigators undertaking research coordinated by the Committee will abide by agreed upon LLRS corporate authorship and acknowledge LLRS support in scholarly dissemination of results
October 29, 2016
Modified Corporate Authorship Guidelines
This document is a brief description of authorship as it pertains to collaborative studies that will be performed under the “Limb Deformity Study Group (LDSG)” – Limb Lengthening and Reconstruction Society branded studies. Analogous to the Canadian Orthopaedic Trauma Society (COTS)
Below are three different types of authorship
1. Individual authorship. This is what we are most familiar with. Example below.
• Bernstein M, Desy NM, Matache BA, McKinley TO, Harvey EJ. A Ten Year Analysis of the Orthopaedic Trauma Association’s Funding Program. J Bone Joint Surg Am. 2013;95e142(1-6). PMID: 24088977
2. Corporate authorship. This is used for larger studies (multiple authors, multiple centers). Advantage is that it eliminates the need to establish order of authors, and there is no need to have a long list of authors in the masthead listings (where all authors would normally appear). The other issue for the editor is that they cannot identify “key authors” who can defend the study in the public forum.
3. Modified corporate authorship. The authors establish a “writing committee” or select few who serve this purpose. They are usually the central group who have selected the study and are “putting in the most time”. Examples below 2, 3:
• FLOW Investigators. Bhandari M, Jeray KJ, et al.: A Trial of Wound Irrigation in the Initial Management of Open Fracture Wounds. N Engl J Med 2015;373:2629-2641.
• Reindl R, Harvey EJ, Berry GK, Rahme E, Canadian Orthopaedic Trauma S: Intramedullary Versus Extramedullary Fixation for Unstable Intertrochanteric Fractures: A Prospective Randomized Controlled Trial. J Bone Joint Surg Am 2015;97:1905-1912.
Mitchell Bernstein, MD, FRCSC
Chris Iobst, MD
S. Robert Rozbruch, MD
Austin T. Fragomen, MD
Jessica C. Rivera, MD
Joseph Hsu, MD
1. Meinert CL: Clinical Trials: Design, Conduct, and Analysis. ed 2nd Edition. New York, NY: Oxford University Press, 2012.
2. Investigators F, Bhandari M, Jeray KJ, et al.: A Trial of Wound Irrigation in the Initial Management of Open Fracture Wounds. N Engl J Med 2015;373:2629-2641.
3. Reindl R, Harvey EJ, Berry GK, Rahme E, Canadian Orthopaedic Trauma S: Intramedullary Versus Extramedullary Fixation for Unstable Intertrochanteric Fractures: A Prospective Randomized Controlled Trial. J Bone Joint Surg Am 2015;97:1905-1912.